Skip to content
healthcare.dev

Nazal

NDC 49873-057, Naphazoline hydrochloride, liquid, from Sato Pharmaceutical Co., Ltd..

Product NDC
49873-057
Status
Listed
Labeler
Sato Pharmaceutical Co., Ltd.
Dosage form
LIQUID
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49873-057 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPHAZOLINE HYDROCHLORIDE50 mg/100mL
Package NDCNDC-11Package
49873-057-01498730057011 BOTTLE in 1 CARTON (49873-057-01) / 30 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49873-057 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49873-057 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49873-057. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.